Visionox · 002387.SZ
Visionox's R&D Expense Fell. Its Development Asset Grew.
The 2025 annual report, pp.195–196, shows CNY218.8 million of new capitalized R&D and CNY157.3 million transferred to intangible assets, not current profit or loss. Development expenditure reached CNY259.5 million in the 2026 interim report, p.153.
Visionox's 2025 R&D expense decline combines lower total investment with higher capitalization. Project movement tables track the cost into intangible assets and an expanding development balance, while the 2026 figures and a new consolidation boundary qualify the interpretation.
Read record- Annual Reports
- Cash Flow
- Development Costs